Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial

INTRODUCTION: We have recently described an increased lymphocytic infiltration rate in breast carcinoma tissue is a significant response predictor for anthracycline/taxane-based neoadjuvant chemotherapy (NACT). The aim of this study was to prospectively validate the tumor-associated lymphocyte infil...

Descripción completa

Detalles Bibliográficos
Autores principales: Issa-Nummer, Yasmin, Darb-Esfahani, Silvia, Loibl, Sibylle, Kunz, Georg, Nekljudova, Valentina, Schrader, Iris, Sinn, Bruno Valentin, Ulmer, Hans-Ullrich, Kronenwett, Ralf, Just, Marianne, Kühn, Thorsten, Diebold, Kurt, Untch, Michael, Holms, Frank, Blohmer, Jens-Uwe, Habeck, Jörg-Olaf, Dietel, Manfred, Overkamp, Friedrich, Krabisch, Petra, von Minckwitz, Gunter, Denkert, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846472/
https://www.ncbi.nlm.nih.gov/pubmed/24312450
http://dx.doi.org/10.1371/journal.pone.0079775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846472/
https://www.ncbi.nlm.nih.gov/pubmed/24312450
http://dx.doi.org/10.1371/journal.pone.0079775

Ejemplares similares